Combining insulin with metformin or an insulin secretagogue in non-obese patients with type 2 diabetes: 12 month, randomised, double blind trial
Research output: Contribution to journal › Journal article › Research › peer-review
OBJECTIVES: To study the effect of insulin treatment in combination with metformin or an insulin secretagogue, repaglinide, on glycaemic regulation in non-obese patients with type 2 diabetes. DESIGN: Randomised, double blind, double dummy, parallel trial. SETTING: Secondary care in Denmark between 2003 and 2006. PARTICIPANTS: Non-obese patients (BMI
Original language | English |
---|---|
Journal | BMJ. British Medical Journal (International Ed.) |
Volume | 339 |
Pages (from-to) | b4324 |
ISSN | 0959-8146 |
Publication status | Published - 2009 |
Bibliographical note
Keywords: Blood Glucose; Carbamates; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Hemoglobin A, Glycosylated; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Patient Compliance; Piperidines; Treatment Outcome; Weight Gain
Export Date: 7 January 2010Source: Scopus
ID: 18765021